NCT03549000 2024-12-13A Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.NovartisPhase 1 Terminated127 enrolled
NCT00014131 2023-10-04Vaccine Therapy in Treating Patients With Kidney CancerLisata Therapeutics, Inc.Phase 1 Terminated9 enrolled
NCT02128230 2021-06-22UARK 2012-02 Trial For High-Risk Myeloma Evaluating Accelerating and Sustaining Complete RemissionUniversity of ArkansasPhase 2 Terminated20 enrolled 7 charts